By Satur C. Ocampo At Ground Level | The Philippine Star Four years ago last June 6, the Cheaper Medicines Law (Republic Act 9502, the Universally Accessible Cheaper and Quality Medicines Act of 2008) passed after contentious debates in the 14th Congress, was...
By MARYA SALAMAT
A 2008 study of the Consumers Action for Empowerment and the Health Action Information Network concluded that a single course of antibiotics amounts to three days’ worth of wages; not much has improved since then.
Even if seriously implemented, the Cheaper Medicines Law would still fail to bring down the prices of medicines because it did not break “the monopoly control of transnational corporations on all aspects” of the drug industry. This monopoly is the main reason why drug prices in the Philippines are among the highest in Asia.
By BENJIE OLIVEROS Analysis Bulatlat.com MANILA -- Sen. Mar Roxas is raising hell about the alleged collusion between the Arroyo government and the pharmaceutical industry to delay if not derail the implementation of Republic Act 9502, or the "Universally...
A law passed last year to bring down the prices of drugs and medicines has not delivered on its promise, according to consumer and health advocates. It failed to break the stranglehold of huge transnational drug companies on the Philippine market. It also squandered an opportunity to develop the local pharmaceutical industry.
A community of readers and supporters that help us sustain our operations through microdonations for as low as $1.
